Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$627,820
-$32,060 QoQ
Shares Held
4,006
-7.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#791
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OARSMAN CAPITAL, INC. holds $20,990,952 across 10 Drug Manufacturers - General names. NVS ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
20,266 | $5,099,736 | |
| 2 | JNJ |
Johnson & Johnson
|
19,140 | $4,860,985 | |
| 3 | AZN |
Astrazeneca PLC
|
16,428 | $3,115,077 | |
| 4 | LLY |
ELI LILLY & Co
|
2,212 | $2,653,139 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
42,777 | $2,464,810 | |
| 6 | AMGN |
Amgen Inc
|
2,694 | $975,551 | |
| 7 | NVS |
Novartis AG
This page
|
4,006 | $627,820 | |
| 8 | PFE |
Pfizer Inc
|
23,471 | $565,181 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $627,820 | 4,006 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $659,880 | 4,320 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $610,764 | 4,430 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $612,858 | 4,779 | Shares | Sole | 2025-11-21 | |
| 2025-06-30 | $614,004 | 5,074 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $597,421 | 5,359 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $544,838 | 5,599 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $670,221 | 5,827 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $623,855 | 5,860 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $598,468 | 6,187 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $637,625 | 6,315 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $633,263 | 6,217 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $633,916 | 6,282 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $595,884 | 6,477 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $616,170 | 6,792 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $544,003 | 7,157 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $624,845 | 7,392 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $709,195 | 8,082 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $658,824 | 7,532 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $680,982 | 8,327 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $796,707 | 8,732 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,628,479 | 19,051 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,272,741 | 24,068 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,116,084 | 24,334 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,336,257 | 26,749 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $949,411 | 11,515 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||